Latest From Biotech Now

BIO Investor Forum Company Snapshot: Opsona Therapeutics

opsona115x76

Opsona Therapeutics will be participating in the upcoming BIO Investor Forum, and will be giving a presentation on their work in the autoimmune/inflammatory diseases and oncology space (among other indications). To learn more about their company, please read one of our final company snapshots below. Company Snapshot What is your company’s lead product or technology? Opsona’s lead product OPN-305 is a fully humanized monoclonal IgG4 antibody targeting Toll-like-receptor-2 (TLR2), which is in clinical development as Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Putting Patients First: Paving a Path to Useful CER

NPC_emailbanner_web

Comparative effectiveness research (CER) has the potential to improve health outcomes by helping people make better-informed decisions. But how do we know that CER will generate information that is useful? On September 30, in Washington, DC, you can be part of a conversation featuring a broad range of health care stakeholders—patients, providers, policymakers, payers, researchers, and those who fund research–by participating in an effort led by the National Health Council to create a framework to Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Hawaiian State Legislature’s Selective Memory toward Papaya Saving Science

Ken-Kamiya-2

In recent years, the papaya fruit has become a leading export for the island of Hawaii with it being the island’s second-largest fruit crop with an estimated value of $18 million.  The fruit has also served as a key source of Vitamins A and C for native Hawaiians, which would otherwise be difficult and expensive for them to obtain elsewhere.  This was not always the case for Hawaiian agriculture, especially as it relates to this Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags:

FDA Consumer Update: Advances in Saving Lives with Blood

AB23475

Every two seconds in the U.S., someone needs a blood transfusion or blood product—people of all ages who are injured, need surgery or who are suffering from illness. The Food and Drug Administration’s primary responsibility with regard to blood and blood products is to assure the safety of patients who receive these life-saving products. In this interview, Richard Davey, M.D., director of the Division of Blood Applications, Office of Blood Research and Review at FDA Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Exploring New Solutions For Neglected Diseases in Developing Countries

SBIR Reauthorization Moves Forward

On Tuesday, BIO Ventures for Global Health (BVGH) announced the completion of the 30th research agreement as part of its partnership with the World Intellectual Property Organization (WIPO) to better enable drug companies to assist researchers in addressing infectious diseases worldwide. The partnership aims to accelerate development of drugs, diagnostics and vaccines for more than 1.5 billion people suffering from malaria, tuberculosis, and other neglected tropical diseases including dengue in developing nations. A recent publication in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,